Cargando…
More breast cancer genes?
A new gene associated with a high risk of breast cancer, termed BRCAX, may exist on chromosome 13q. Tumours from multicase Nordic breast cancer families, in which mutations in BRCA1 and BRCA2 had been excluded, were analyzed using comparative genomic hybridization in order to identify a region of in...
Autor principal: | |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2001
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC138680/ https://www.ncbi.nlm.nih.gov/pubmed/11305950 http://dx.doi.org/10.1186/bcr290 |
_version_ | 1782120472486346752 |
---|---|
author | Hopper, John L |
author_facet | Hopper, John L |
author_sort | Hopper, John L |
collection | PubMed |
description | A new gene associated with a high risk of breast cancer, termed BRCAX, may exist on chromosome 13q. Tumours from multicase Nordic breast cancer families, in which mutations in BRCA1 and BRCA2 had been excluded, were analyzed using comparative genomic hybridization in order to identify a region of interest, which was apparently confirmed and refined using linkage analysis on an independent sample. The present commentary discusses this work. It also asks why there should exist genetic variants associated with susceptibility to breast cancer other than mutations in BRCA1 and BRCA2, and what might be their modes of inheritance, allele frequencies and risks. Replication studies will be needed to clarify whether there really is a tumour suppressor gene other than BRCA2 on chromosome 13q. |
format | Text |
id | pubmed-138680 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2001 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-1386802003-02-27 More breast cancer genes? Hopper, John L Breast Cancer Res Commentary A new gene associated with a high risk of breast cancer, termed BRCAX, may exist on chromosome 13q. Tumours from multicase Nordic breast cancer families, in which mutations in BRCA1 and BRCA2 had been excluded, were analyzed using comparative genomic hybridization in order to identify a region of interest, which was apparently confirmed and refined using linkage analysis on an independent sample. The present commentary discusses this work. It also asks why there should exist genetic variants associated with susceptibility to breast cancer other than mutations in BRCA1 and BRCA2, and what might be their modes of inheritance, allele frequencies and risks. Replication studies will be needed to clarify whether there really is a tumour suppressor gene other than BRCA2 on chromosome 13q. BioMed Central 2001 2001-03-29 /pmc/articles/PMC138680/ /pubmed/11305950 http://dx.doi.org/10.1186/bcr290 Text en Copyright © 2001 BioMed Central Ltd |
spellingShingle | Commentary Hopper, John L More breast cancer genes? |
title | More breast cancer genes? |
title_full | More breast cancer genes? |
title_fullStr | More breast cancer genes? |
title_full_unstemmed | More breast cancer genes? |
title_short | More breast cancer genes? |
title_sort | more breast cancer genes? |
topic | Commentary |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC138680/ https://www.ncbi.nlm.nih.gov/pubmed/11305950 http://dx.doi.org/10.1186/bcr290 |
work_keys_str_mv | AT hopperjohnl morebreastcancergenes |